Clinical trial
AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations
NCT03310541
Study timeline
Study start (actual)2017-10-11Date precision: day
Registry last updated2023-05-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
AZD5363DRUG
EnzalutamideDRUG · verified · RxNorm: enzalutamide
FulvestrantDRUG · verified · RxNorm: fulvestrant
Sponsors & collaborators
Memorial Sloan Kettering Cancer Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03310541 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.